Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.07 trillion and total revenue of $110.03 billion.
Market Cap
1.07T
Revenue
110.03B
Profits
-41.17B
PE Ratio
n/a
Profit Margin
-37.41%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.58B | 1.42% | 1,200,058 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.23B | 1.05% | 553,091 | 14.34B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.59B | 6.70% | 1,139,648 | 3.71B |
| 4 | ARGX | argenx SE | 43.14B | 2.89% | 421,259 | 4.24B |
| 5 | INSM | Insmed Incorporated | 31.97B | 6.59% | 1,987,371 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 31.42B | 2.81% | 160,307 | 5.34B |
| 7 | BNTX | BioNTech SE | 22.31B | 2.26% | 651,384 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 21.15B | 4.29% | 4,467,876 | 1.94B |
| 9 | RPRX | Royalty Pharma plc | 20.15B | 3.20% | 3,268,147 | 2.38B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.58B | 1.82% | 3,286,442 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 18.69B | -1.29% | 2,483,676 | - |
| 12 | INCY | Incyte Corporation | 18.36B | 1.78% | 1,055,737 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.90B | 1.16% | 3,154,045 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 13.91B | 15.44% | 5,269,299 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.88B | 4.49% | 1,261,319 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.56B | 2.49% | 294,724 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.01B | 4.33% | 2,994,309 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.64B | 2.20% | 833,396 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 11.11B | 2.92% | 1,832,270 | 2.32B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.69B | 2.77% | 1,947,353 | 3.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.60B | 3.80% | 303,515 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 8.69B | 0.48% | 783,004 | 5.37M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.69B | 5.86% | 352,742 | 7.46M |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.51B | 8.00% | 3,389,740 | 1.09B |
| 25 | IBRX | ImmunityBio, Inc. | 8.30B | 8.76% | 29,057,430 | 113.29M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.28B | 1.91% | 434,893 | 638.50M |
| 27 | TECH | Bio-Techne Corporation | 8.24B | 0.50% | 1,598,227 | 1.22B |
| 28 | PCVX | Vaxcyte, Inc. | 8.05B | 2.27% | 1,725,275 | - |
| 29 | NUVL | Nuvalent, Inc. | 7.70B | 1.92% | 707,656 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 7.68B | 3.95% | 2,102,618 | 88.04M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.46B | 1.93% | 882,070 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.45B | 3.18% | 240,464 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.70B | -0.13% | 1,124,161 | 22.29M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.66B | 3.90% | 812,176 | 46.02M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.44B | 6.06% | 934,951 | 39.21M |
| 36 | BLTE | Belite Bio, Inc | 6.10B | 2.79% | 126,805 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 5.92B | 4.41% | 2,298,377 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.78B | 2.46% | 1,154,448 | 189.76M |
| 39 | CGON | CG Oncology, Inc. | 5.56B | 3.09% | 755,049 | 4.04M |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.53B | 3.42% | 684,787 | 1.73B |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.46B | 7.58% | 3,533,056 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.44B | 2.61% | 614,546 | 521.31M |
| 43 | XENE | Xenon Pharmaceuticals Inc. | 5.30B | 4.10% | 1,833,819 | 7.50M |
| 44 | CAI | Caris Life Sciences, Inc. | 5.24B | -3.53% | 1,915,411 | 812.03M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.22B | 7.40% | 1,715,195 | - |
| 46 | CELC | Celcuity Inc. | 5.10B | 8.05% | 850,035 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.08B | 5.29% | 2,055,343 | 616.29M |
| 48 | IMVT | Immunovant, Inc. | 5.04B | 3.86% | 1,008,611 | - |
| 49 | ERAS | Erasca, Inc. | 4.97B | 9.00% | 5,661,266 | - |
| 50 | TERN | Terns Pharmaceuticals, Inc. | 4.76B | 5.72% | 81,332,874 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.14% | 2,112,146 | 634.21M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.52B | 1.42% | 1,081,182 | 3.51M |
| 53 | CORT | Corcept Therapeutics Incorporated | 4.30B | 19.66% | 11,743,400 | 761.41M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.08B | 1.44% | 140,304 | 268.09M |
| 55 | VKTX | Viking Therapeutics, Inc. | 3.84B | 3.20% | 1,906,981 | - |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.80B | 5.73% | 1,246,209 | 7.70M |
| 57 | CNTA | Centessa Pharmaceuticals plc | 3.79B | 1.18% | 2,178,145 | 15.00M |
| 58 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | 5.01% | 2,357,271 | 1.07B |
| 59 | SYRE | Spyre Therapeutics, Inc. | 3.59B | 8.20% | 667,978 | - |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.57B | 3.16% | 740,819 | 22.50M |
| 61 | DNLI | Denali Therapeutics Inc. | 3.56B | 7.15% | 5,408,026 | - |
| 62 | DNTH | Dianthus Therapeutics, Inc. | 3.54B | 1.35% | 1,051,653 | 2.04M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.43B | 4.24% | 767,931 | - |
| 64 | GPCR | Structure Therapeutics Inc. | 3.41B | 2.32% | 636,530 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.26B | 2.98% | 1,129,257 | 1.03B |
| 66 | ALMS | Alumis Inc. | 3.16B | 7.54% | 1,854,768 | 24.05M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.13B | 6.33% | 2,830,749 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.02B | 1.48% | 125,913 | 803.79M |
| 69 | TNGX | Tango Therapeutics, Inc. | 2.98B | 7.19% | 4,365,759 | 62.38M |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.91B | 3.16% | 1,006,318 | 588.99M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.90B | 4.27% | 1,154,872 | 70.85M |
| 72 | VERA | Vera Therapeutics, Inc. | 2.87B | 1.03% | 1,411,497 | - |
| 73 | TARS | Tarsus Pharmaceuticals, Inc. | 2.85B | 6.03% | 414,562 | 451.36M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.82B | 4.17% | 821,160 | 376.07M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 2.76B | 2.82% | 854,316 | 218.71M |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.69B | 5.98% | 847,112 | 247.00M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.54B | 2.87% | 1,569,932 | 490.73M |
| 78 | SRPT | Sarepta Therapeutics, Inc. | 2.50B | 34.98% | 17,077,287 | 2.20B |
| 79 | MANE | Veradermics, Incorporated | 2.45B | 3.26% | 467,259 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.39B | 4.93% | 466,827 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.35B | -3.47% | 5,332,653 | 139.74M |
| 82 | WVE | Wave Life Sciences Ltd. | 2.32B | 5.76% | 3,610,463 | 42.73M |
| 83 | IMNM | Immunome, Inc. | 2.30B | 0.45% | 1,443,898 | 6.94M |
| 84 | ADMA | ADMA Biologics, Inc. | 2.29B | -15.00% | 32,479,451 | 510.17M |
| 85 | APLS | Apellis Pharmaceuticals, Inc. | 2.27B | 2.84% | 1,871,302 | 1.00B |
| 86 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.05% | 1,816,662 | 158.18M |
| 87 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | 1.80% | 2,165,486 | 276.98M |
| 88 | ORKA | Oruka Therapeutics, Inc. | 2.17B | 9.80% | 814,520 | - |
| 89 | SNDX | Syndax Pharmaceuticals, Inc. | 2.13B | 0.75% | 1,558,225 | 172.35M |
| 90 | ELVN | Enliven Therapeutics, Inc. | 2.12B | 14.06% | 6,421,119 | - |
| 91 | CLDX | Celldex Therapeutics, Inc. | 2.11B | 1.57% | 657,004 | 1.55M |
| 92 | AAPG | Ascentage Pharma Group International | 2.08B | 0.27% | 727 | 54.52M |
| 93 | NKTR | Nektar Therapeutics | 2.07B | -1.21% | 1,022,216 | 55.23M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.03B | 7.60% | 1,093,196 | - |
| 95 | ZLAB | Zai Lab Limited | 2.02B | 4.69% | 553,016 | 460.16M |
| 96 | GLPG | Galapagos NV | 2.02B | 2.82% | 381,011 | 1.31B |
| 97 | MESO | Mesoblast Limited | 2.02B | 9.29% | 318,116 | 65.38M |
| 98 | STOK | Stoke Therapeutics, Inc. | 2.00B | 5.00% | 1,111,057 | 184.42M |
| 99 | TYRA | Tyra Biosciences, Inc. | 1.98B | 1.07% | 757,303 | - |
| 100 | RARE | Ultragenyx Pharmaceutical Inc. | 1.92B | 7.30% | 1,892,301 | 673.00M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.91B | 1.13% | 980,151 | 283.06M |
| 102 | ANAB | AnaptysBio, Inc. | 1.88B | 3.76% | 284,044 | 234.60M |
| 103 | DFTX | Definium Therapeutics, Inc. | 1.84B | 3.82% | 2,508,324 | - |
| 104 | OCUL | Ocular Therapeutix, Inc. | 1.81B | 2.84% | 3,471,766 | 51.95M |
| 105 | ZYME | Zymeworks Inc. | 1.79B | 2.67% | 522,630 | 105.97M |
| 106 | AGIO | Agios Pharmaceuticals, Inc. | 1.73B | 4.37% | 726,342 | 54.03M |
| 107 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 3.57% | 1,056,706 | 11.13M |
| 108 | RLAY | Relay Therapeutics, Inc. | 1.72B | 1.69% | 1,499,884 | 15.36M |
| 109 | INVA | Innoviva, Inc. | 1.67B | 3.06% | 568,274 | 411.33M |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | - | 13,551,585 | 74.68M |
| 111 | SION | Sionna Therapeutics, Inc. | 1.67B | 6.67% | 285,593 | - |
| 112 | SLNO | Soleno Therapeutics, Inc. | 1.64B | 1.60% | 1,264,270 | 190.41M |
| 113 | VCEL | Vericel Corporation | 1.60B | -4.96% | 2,017,310 | 276.26M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | 1.81% | 558,512 | 868.45M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.59B | 6.93% | 2,161,129 | 83.98M |
| 116 | MAZE | Maze Therapeutics, Inc. | 1.58B | -35.24% | 8,232,095 | 2.50M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 3.51% | 3,006,142 | 67.67M |
| 118 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | 3.59% | 10,577,448 | 263.50M |
| 119 | IMCR | Immunocore Holdings plc | 1.54B | 1.10% | 368,504 | 400.02M |
| 120 | NUVB | Nuvation Bio Inc. | 1.52B | 2.34% | 2,539,718 | 62.90M |
| 121 | NVAX | Novavax, Inc. | 1.52B | 0.86% | 2,708,871 | 1.12B |
| 122 | DMRA | Damora Therapeutics, Inc. | 1.51B | 4.72% | 143,365 | - |
| 123 | GENB | Generate Biomedicines, Inc. | 1.51B | -1.66% | 472,962 | 31.89M |
| 124 | NBTX | Nanobiotix S.A. | 1.48B | 4.65% | 103,510 | 11.93M |
| 125 | OCS | Oculis Holding AG | 1.48B | 1.96% | 323,374 | 1.51M |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.47B | 7.52% | 1,137,307 | - |
| 127 | PHVS | Pharvaris N.V. | 1.43B | 3.20% | 80,805 | - |
| 128 | PVLA | Palvella Therapeutics, Inc. | 1.42B | 3.58% | 261,588 | - |
| 129 | ARDX | Ardelyx, Inc. | 1.38B | 5.42% | 2,509,880 | 407.32M |
| 130 | RAPP | Rapport Therapeutics, Inc. | 1.38B | 2.23% | 305,638 | - |
| 131 | MBX | MBX Biosciences, Inc. | 1.38B | 4.10% | 337,181 | - |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.32B | 10.90% | 3,144,555 | 9.77M |
| 133 | IMTX | Immatics N.V. | 1.31B | 5.87% | 807,667 | 56.67M |
| 134 | BHVN | Biohaven Ltd. | 1.30B | 2.62% | 1,818,354 | - |
| 135 | MLTX | MoonLake Immunotherapeutics | 1.29B | 7.84% | 710,329 | - |
| 136 | ATAI | AtaiBeckley Inc. | 1.29B | 4.73% | 3,235,197 | 4.09M |
| 137 | ZBIO | Zenas BioPharma, Inc. | 1.27B | 5.37% | 468,040 | 10.00M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.26B | 6.73% | 1,319,253 | 123.67M |
| 139 | VIR | Vir Biotechnology, Inc. | 1.25B | 4.90% | 2,440,648 | 68.56M |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.24B | 1.72% | 1,386,158 | - |
| 141 | KOD | Kodiak Sciences Inc. | 1.21B | 4.12% | 758,752 | - |
| 142 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | 8.14% | 1,299,561 | - |
| 143 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | 5.41% | 1,037,292 | - |
| 144 | PHAR | Pharming Group N.V. | 1.11B | 1.63% | 13,457 | 376.13M |
| 145 | PGEN | Precigen, Inc. | 1.10B | -0.96% | 6,729,079 | 9.68M |
| 146 | EYPT | EyePoint, Inc. | 1.09B | 3.65% | 687,427 | 31.37M |
| 147 | SEPN | Septerna, Inc. | 1.09B | 3.28% | 134,209 | 45.95M |
| 148 | SVRA | Savara Inc. | 1.08B | 4.76% | 1,648,762 | - |
| 149 | TVGN | Tevogen Bio Holdings Inc. | 1.05B | -0.77% | 29,063 | - |
| 150 | ABCL | AbCellera Biologics Inc. | 1.03B | 2.42% | 1,687,179 | 75.13M |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.02B | 2.86% | 364,879 | - |
| 152 | QURE | uniQure N.V. | 1.02B | 7.77% | 1,373,195 | 16.10M |
| 153 | GERN | Geron Corporation | 1.01B | 3.97% | 14,540,204 | 183.88M |
| 154 | AVBP | ArriVent BioPharma, Inc. | 1.01B | 3.64% | 239,747 | - |
| 155 | CMPX | Compass Therapeutics, Inc. | 988.68M | 3.00% | 1,366,820 | 850.00K |
| 156 | AKTS | Aktis Oncology, Inc. | 979.02M | 0.05% | 270,611 | 5.56M |
| 157 | INBX | Inhibrx Biosciences, Inc. | 970.78M | 5.29% | 196,097 | 1.30M |
| 158 | SLS | SELLAS Life Sciences Group, Inc. | 951.79M | 6.11% | 5,616,194 | - |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | 913.89M | 0.19% | 2,406,776 | 291.85M |
| 160 | XNCR | Xencor, Inc. | 909.40M | 4.29% | 638,278 | 125.58M |
| 161 | ABUS | Arbutus Biopharma Corporation | 885.52M | 5.10% | 2,547,915 | 14.08M |
| 162 | FTRE | Fortrea Holdings Inc. | 882.64M | -1.46% | 889,700 | 2.72B |
| 163 | URGN | UroGen Pharma Ltd. | 882.12M | 2.60% | 346,947 | 109.79M |
| 164 | KALV | KalVista Pharmaceuticals, Inc. | 866.36M | 4.13% | 1,720,025 | 73.62M |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 851.00M | 3.08% | 1,159,746 | - |
| 166 | GHRS | GH Research PLC | 846.70M | 1.94% | 72,621 | - |
| 167 | SGP | SpyGlass Pharma, Inc. | 840.27M | 6.23% | 72,584 | - |
| 168 | JANX | Janux Therapeutics, Inc. | 839.48M | 1.77% | 1,244,118 | 10.00M |
| 169 | IVA | Inventiva S.A. | 837.69M | - | 181,266 | 19.93M |
| 170 | EVMN | Evommune, Inc. | 833.10M | 10.04% | 477,190 | 13.00M |
| 171 | SANA | Sana Biotechnology, Inc. | 827.29M | 6.16% | 3,300,717 | - |
| 172 | PHAT | Phathom Pharmaceuticals, Inc. | 825.02M | 4.08% | 836,679 | 175.11M |
| 173 | MPLT | MapLight Therapeutics, Inc. | 791.66M | 6.83% | 173,402 | - |
| 174 | ANL | Adlai Nortye Ltd. | 788.19M | 1.86% | 147,035 | -1.35M |
| 175 | TBPH | Theravance Biopharma, Inc. | 787.33M | 2.62% | 550,789 | 107.46M |
| 176 | SPRY | ARS Pharmaceuticals, Inc. | 784.45M | 4.77% | 1,869,578 | 84.28M |
| 177 | KURA | Kura Oncology, Inc. | 755.22M | 5.95% | 1,010,647 | 67.48M |
| 178 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 740.30M | 6.08% | 97,773 | - |
| 179 | OMER | Omeros Corporation | 740.20M | 2.55% | 633,372 | - |
| 180 | CTMX | CytomX Therapeutics, Inc. | 718.19M | -0.47% | 6,111,852 | 76.20M |
| 181 | DRUG | Bright Minds Biosciences Inc. | 715.32M | 2.65% | 151,238 | - |
| 182 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | -2.33% | 2,731,167 | 49.80M |
| 183 | SLDB | Solid Biosciences Inc. | 711.37M | 8.23% | 793,847 | - |
| 184 | MNKD | MannKind Corporation | 702.47M | -0.44% | 6,324,224 | 348.97M |
| 185 | RLMD | Relmada Therapeutics, Inc. | 698.57M | 9.18% | 1,651,325 | - |
| 186 | ARVN | Arvinas, Inc. | 698.45M | 6.12% | 547,493 | 262.60M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 696.20M | 3.46% | 100,636 | 116.59M |
| 188 | JBIO | Jade Biosciences, Inc. | 687.96M | 5.20% | 375,039 | - |
| 189 | DSGN | Design Therapeutics, Inc. | 661.74M | 4.07% | 317,783 | - |
| 190 | ANRO | Alto Neuroscience, Inc. | 660.31M | 2.38% | 186,075 | - |
| 191 | PRME | Prime Medicine, Inc. | 655.40M | 3.12% | 2,257,563 | 4.63M |
| 192 | ANNX | Annexon, Inc. | 641.83M | 7.30% | 2,173,578 | - |
| 193 | OCGN | Ocugen, Inc. | 639.40M | 1.56% | 12,756,387 | 4.41M |
| 194 | AGMB | AgomAb Therapeutics NV | 626.75M | 10.39% | 147,682 | - |
| 195 | REPL | Replimune Group, Inc. | 624.25M | 8.46% | 2,107,285 | - |
| 196 | DRTS | Alpha Tau Medical Ltd. | 621.35M | 0.71% | 211,013 | - |
| 197 | MGTX | MeiraGTx Holdings plc | 613.34M | 2.83% | 432,801 | 27.42M |
| 198 | LBRX | LB Pharmaceuticals Inc | 612.49M | 3.59% | 172,320 | - |
| 199 | MDXG | MiMedx Group, Inc. | 609.12M | -0.73% | 579,040 | 418.63M |
| 200 | EIKN | Eikon Therapeutics, Inc. | 597.61M | 0.09% | 476,267 | - |
| 201 | TECX | Tectonic Therapeutic, Inc. | 583.20M | 3.29% | 204,416 | - |
| 202 | ALLO | Allogene Therapeutics, Inc. | 568.00M | 5.43% | 4,402,948 | 22.00K |
| 203 | VALN | Valneva SE | 561.87M | 0.93% | 371,709 | 205.07M |
| 204 | DBVT | DBV Technologies S.A. | 554.84M | 3.68% | 348,374 | 5.50M |
| 205 | YDES | YD Bio Limited | 538.65M | -0.91% | 21,823 | 510.36K |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 536.04M | -0.22% | 620,125 | 106.47M |
| 207 | ZURA | Zura Bio Limited | 533.23M | 4.46% | 752,792 | - |
| 208 | CRMD | CorMedix Inc. | 522.52M | 2.32% | 918,122 | 311.71M |
| 209 | UPB | Upstream Bio, Inc. | 511.75M | 12.07% | 687,019 | 2.80M |
| 210 | RCKT | Rocket Pharmaceuticals, Inc. | 508.10M | 9.60% | 4,527,887 | - |
| 211 | FDMT | 4D Molecular Therapeutics, Inc. | 504.39M | 7.63% | 895,608 | 85.21M |
| 212 | ADCT | ADC Therapeutics SA | 504.37M | 0.76% | 523,473 | 81.36M |
| 213 | PRTA | Prothena Corporation plc | 501.19M | 6.64% | 543,667 | 9.68M |
| 214 | CTNM | Contineum Therapeutics, Inc. | 495.82M | 7.70% | 128,960 | - |
| 215 | NAUT | Nautilus Biotechnology, Inc. | 493.85M | -1.01% | 1,009,662 | - |
| 216 | LRMR | Larimar Therapeutics, Inc. | 486.17M | 2.41% | 4,524,736 | - |
| 217 | RIGL | Rigel Pharmaceuticals, Inc. | 485.66M | 0.61% | 221,798 | 294.28M |
| 218 | ENGN | enGene Holdings Inc. | 473.62M | 2.46% | 114,314 | - |
| 219 | IMMX | Immix Biopharma, Inc. | 471.91M | 3.97% | 768,749 | - |
| 220 | LYEL | Lyell Immunopharma, Inc. | 469.41M | 2.23% | 79,805 | 36.00K |
| 221 | FULC | Fulcrum Therapeutics, Inc. | 464.87M | 4.18% | 507,376 | 80.00M |
| 222 | TRDA | Entrada Therapeutics, Inc. | 461.33M | 5.06% | 136,362 | 25.42M |
| 223 | STTK | Shattuck Labs, Inc. | 455.86M | 4.08% | 631,193 | 1.00M |
| 224 | MRVI | Maravai LifeSciences Holdings, Inc. | 455.25M | 0.97% | 1,292,159 | 185.74M |
| 225 | ASMB | Assembly Biosciences, Inc. | 454.78M | 1.56% | 58,377 | 72.30M |
| 226 | VSTM | Verastem, Inc. | 447.08M | 3.25% | 2,551,032 | 30.91M |
| 227 | ABSI | Absci Corporation | 446.82M | -2.99% | 7,140,391 | 2.80M |
| 228 | IVVD | Invivyd, Inc. | 440.85M | 9.09% | 2,116,352 | 53.43M |
| 229 | RGNX | REGENXBIO Inc. | 436.65M | 8.32% | 930,901 | 170.44M |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.23M | 2.76% | 154,075 | - |
| 231 | DNA | Ginkgo Bioworks Holdings, Inc. | 433.68M | 2.65% | 1,046,724 | 170.16M |
| 232 | ACRS | Aclaris Therapeutics, Inc. | 432.94M | 8.79% | 1,584,335 | 7.83M |
| 233 | AVIR | Atea Pharmaceuticals, Inc. | 432.62M | 1.88% | 421,160 | - |
| 234 | ALT | Altimmune, Inc. | 430.53M | 2.16% | 4,369,469 | 41.00K |
| 235 | VNDA | Vanda Pharmaceuticals Inc. | 428.53M | 6.30% | 1,257,771 | 216.11M |
| 236 | NMRA | Neumora Therapeutics, Inc. | 417.72M | 1.21% | 766,246 | - |
| 237 | LXEO | Lexeo Therapeutics, Inc. | 417.49M | 4.00% | 719,343 | - |
| 238 | AURA | Aura Biosciences, Inc. | 411.50M | 2.69% | 268,300 | - |
| 239 | STRO | Sutro Biopharma, Inc. | 389.25M | -0.32% | 467,583 | 102.48M |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 386.09M | 4.73% | 1,614,286 | 14.56M |
| 241 | PRTC | PureTech Health plc | 382.24M | 1.08% | 340 | 6.39M |
| 242 | MNPR | Monopar Therapeutics Inc. | 380.57M | 3.08% | 250,861 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 372.40M | 1.31% | 108,569 | - |
| 244 | IPSC | Century Therapeutics, Inc. | 372.03M | -7.59% | 1,128,593 | 109.16M |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 371.86M | 7.07% | 402,518 | 35.11M |
| 246 | CADL | Candel Therapeutics, Inc. | 365.50M | 3.74% | 1,203,376 | - |
| 247 | NAGE | Niagen Bioscience, Inc. | 361.96M | -0.44% | 674,055 | 129.42M |
| 248 | GLSI | Greenwich LifeSciences, Inc. | 360.08M | 1.21% | 137,637 | - |
| 249 | XOMA | XOMA Royalty Corporation | 359.55M | 3.35% | 100,849 | 52.15M |
| 250 | DMAC | DiaMedica Therapeutics Inc. | 357.25M | -0.44% | 198,275 | - |
| 251 | AUTL | Autolus Therapeutics plc | 353.97M | 0.76% | 2,478,808 | 51.13M |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 353.17M | 0.75% | 145,355 | 66.98M |
| 253 | KYTX | Kyverna Therapeutics, Inc. | 344.68M | 3.01% | 610,477 | - |
| 254 | IMRX | Immuneering Corporation | 343.95M | 1.72% | 545,526 | - |
| 255 | NGNE | Neurogene Inc. | 343.10M | 5.41% | 178,180 | 925.00K |
| 256 | IRD | Opus Genetics, Inc. | 337.96M | 5.32% | 389,732 | 14.20M |
| 257 | PEPG | PepGen Inc. | 337.28M | 3.39% | 698,526 | - |
| 258 | CLYM | Climb Bio, Inc. | 333.42M | 4.49% | 547,778 | - |
| 259 | PALI | Palisade Bio, Inc. | 331.77M | - | 4,558,168 | - |
| 260 | FBRX | Forte Biosciences, Inc. | 330.46M | 2.57% | 302,316 | - |
| 261 | BCYC | Bicycle Therapeutics plc | 326.23M | 4.00% | 1,095,856 | 72.59M |
| 262 | CBIO | Crescent Biopharma, Inc. | 324.62M | 12.84% | 279,515 | 10.84M |
| 263 | PBYI | Puma Biotechnology, Inc. | 322.05M | 1.12% | 211,414 | 228.37M |
| 264 | AVTX | Avalo Therapeutics, Inc. | 317.90M | 3.72% | 1,149,859 | 59.00K |
| 265 | OVID | Ovid Therapeutics Inc. | 316.50M | -0.83% | 2,509,122 | 7.25M |
| 266 | ARMP | Armata Pharmaceuticals, Inc. | 315.41M | 4.87% | 35,813 | 4.90M |
| 267 | CABA | Cabaletta Bio, Inc. | 309.48M | 4.12% | 1,490,987 | - |
| 268 | NBP | NovaBridge Biosciences | 304.37M | 4.76% | 886,725 | - |
| 269 | RZLT | Rezolute, Inc. | 304.32M | 18.22% | 12,761,740 | - |
| 270 | SRZN | Surrozen, Inc. | 300.26M | 4.56% | 47,046 | 3.48M |
| 271 | ACIU | AC Immune SA | 299.21M | 2.80% | 129,414 | 4.51M |
| 272 | PLYX | Polaryx Therapeutics, Inc. | 297.32M | -2.48% | 232,929 | - |
| 273 | FHTX | Foghorn Therapeutics Inc. | 289.39M | 2.71% | 122,419 | 30.91M |
| 274 | TARA | Protara Therapeutics, Inc. | 287.19M | 5.99% | 435,557 | - |
| 275 | ENLV | Enlivex Ltd. | 284.86M | 9.09% | 12,601,370 | - |
| 276 | LENZ | LENZ Therapeutics, Inc. | 284.38M | 0.44% | 1,426,395 | 19.09M |
| 277 | ALXO | ALX Oncology Holdings Inc. | 268.48M | - | 1,208,288 | - |
| 278 | OBIO | Orchestra BioMed Holdings, Inc. | 267.44M | -1.93% | 199,845 | 33.48M |
| 279 | CHRS | Coherus Oncology, Inc. | 265.31M | 3.51% | 2,295,966 | 42.17M |
| 280 | NERV | Minerva Neurosciences, Inc. | 263.97M | 0.99% | 175,782 | - |
| 281 | CCCC | C4 Therapeutics, Inc. | 262.49M | 7.60% | 1,351,701 | 35.95M |
| 282 | PROK | ProKidney Corp. | 259.76M | 2.23% | 811,579 | 893.00K |
| 283 | SLN | Silence Therapeutics plc | 258.37M | 5.19% | 477,686 | 559.00K |
| 284 | AVXL | Anavex Life Sciences Corp. | 253.92M | -34.61% | 14,061,074 | - |
| 285 | ABEO | Abeona Therapeutics Inc. | 252.16M | 2.08% | 1,195,480 | 5.82M |
| 286 | CLLS | Cellectis S.A. | 247.79M | 4.33% | 44,554 | 79.59M |
| 287 | CAMP | Camp4 Therapeutics Corporation | 246.62M | 4.86% | 105,306 | 3.50M |
| 288 | CNTX | Context Therapeutics Inc. | 245.32M | -16.04% | 1,724,393 | - |
| 289 | TENX | Tenax Therapeutics, Inc. | 240.77M | 5.82% | 363,085 | - |
| 290 | VYGR | Voyager Therapeutics, Inc. | 240.19M | 2.81% | 483,633 | 40.37M |
| 291 | ALEC | Alector, Inc. | 239.49M | 4.33% | 589,311 | 21.05M |
| 292 | HELP | Cybin Inc. | 237.67M | 5.32% | 717,971 | - |
| 293 | OABI | OmniAb, Inc. | 234.55M | -2.99% | 216,996 | 18.67M |
| 294 | EDIT | Editas Medicine, Inc. | 227.06M | 3.11% | 1,032,709 | 40.52M |
| 295 | KROS | Keros Therapeutics, Inc. | 223.60M | 3.18% | 356,013 | 244.06M |
| 296 | ELDN | Eledon Pharmaceuticals, Inc. | 221.49M | 1.04% | 934,244 | - |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 220.30M | -1.17% | 67,713 | 19.39M |
| 298 | MDWD | MediWound Ltd. | 217.94M | 2.23% | 45,648 | 16.96M |
| 299 | NVCT | Nuvectis Pharma, Inc. | 210.87M | 0.13% | 78,044 | - |
| 300 | PRLD | Prelude Therapeutics Incorporated | 205.39M | 4.49% | 99,848 | 12.14M |
| 301 | ELTX | Elicio Therapeutics, Inc. | 201.62M | 3.89% | 94,285 | - |
| 302 | MGNX | MacroGenics, Inc. | 201.47M | 16.12% | 1,659,010 | 149.50M |
| 303 | TNXP | Tonix Pharmaceuticals Holding Corp. | 201.08M | -2.22% | 336,008 | 13.11M |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 200.67M | 6.17% | 494,587 | 82.03M |
| 305 | CBUS | Cibus, Inc. | 198.59M | 5.90% | 312,980 | 3.64M |
| 306 | CGEN | Compugen Ltd. | 194.78M | -0.48% | 120,693 | 72.76M |
| 307 | SABS | SAB Biotherapeutics, Inc. | 194.63M | -1.29% | 790,685 | 114.70K |
| 308 | ADAG | Adagene Inc. | 191.82M | 12.74% | 160,264 | 103.20K |
| 309 | GALT | Galectin Therapeutics Inc. | 188.91M | 3.53% | 168,783 | - |
| 310 | CNTB | Connect Biopharma Holdings Limited | 187.84M | 7.35% | 468,124 | 762.00K |
| 311 | ZNTL | Zentalis Pharmaceuticals, Inc. | 184.24M | 3.24% | 343,287 | 26.87M |
| 312 | CRBU | Caribou Biosciences, Inc. | 181.68M | 3.30% | 641,912 | 11.16M |
| 313 | CNTN | Canton Strategic Holdings, Inc. | 178.77M | 6.77% | 572,200 | - |
| 314 | PLX | Protalix BioTherapeutics, Inc. | 173.71M | 4.35% | 1,105,807 | 52.74M |
| 315 | FENC | Fennec Pharmaceuticals Inc. | 173.48M | 2.49% | 371,763 | 44.64M |
| 316 | IMUX | Immunic, Inc. | 172.21M | 5.60% | 1,999,397 | - |
| 317 | WHWK | Whitehawk Therapeutics, Inc. | 169.44M | - | 92,374 | 7.15M |
| 318 | PRQR | ProQR Therapeutics N.V. | 166.47M | 6.04% | 226,912 | 19.19M |
| 319 | RNAC | Cartesian Therapeutics, Inc. | 165.68M | 2.97% | 150,513 | 2.80M |
| 320 | MOLN | Molecular Partners AG | 161.25M | -0.92% | 1,310 | 856.30K |
| 321 | NTHI | NeOnc Technologies Holdings, Inc. | 160.66M | -5.98% | 25,447 | 59.99K |
| 322 | DTIL | Precision BioSciences, Inc. | 159.98M | 1.09% | 210,811 | 34.26M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 159.31M | 1.54% | 426,344 | - |
| 324 | CDXS | Codexis, Inc. | 159.02M | 4.79% | 1,155,931 | 70.39M |
| 325 | KRRO | Korro Bio, Inc. | 157.49M | 3.21% | 228,528 | 6.39M |
| 326 | TNYA | Tenaya Therapeutics, Inc. | 156.76M | -4.62% | 3,714,985 | - |
| 327 | MENS | Jyong Biotech Ltd. | 155.15M | 4.50% | 176,321 | - |
| 328 | EVAX | Evaxion A/S | 154.29M | 0.68% | 10,039 | 7.53M |
| 329 | HUMA | Humacyte, Inc. | 154.12M | 3.60% | 7,502,340 | 1.57M |
| 330 | MIST | Milestone Pharmaceuticals Inc. | 153.31M | 7.76% | 1,782,545 | 1.55M |
| 331 | NKTX | Nkarta, Inc. | 151.85M | 3.90% | 414,772 | - |
| 332 | VTVT | vTv Therapeutics Inc. | 150.85M | 5.77% | 68,381 | 17.00K |
| 333 | SGMT | Sagimet Biosciences Inc. | 150.54M | -0.22% | 582,318 | - |
| 334 | ACHV | Achieve Life Sciences, Inc. | 150.14M | -2.76% | 2,414,270 | - |
| 335 | HRTX | Heron Therapeutics, Inc. | 150.13M | 4.16% | 1,825,656 | 154.90M |
| 336 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 147.39M | 1.59% | 216,709 | - |
| 337 | UNCY | Unicycive Therapeutics, Inc. | 142.92M | 4.07% | 484,767 | - |
| 338 | PMN | ProMIS Neurosciences, Inc. | 142.14M | -9.06% | 22,054 | - |
| 339 | FATE | Fate Therapeutics, Inc. | 141.84M | 7.96% | 2,036,275 | 6.65M |
| 340 | KLRS | Kalaris Therapeutics, Inc. | 140.21M | -1.37% | 60,450 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 139.31M | 2.34% | 83,636 | 2.00M |
| 342 | AGEN | Agenus Inc. | 136.70M | - | 255,487 | 114.20M |
| 343 | SPRO | Spero Therapeutics, Inc. | 135.78M | 1.69% | 189,258 | 40.55M |
| 344 | ARTV | Artiva Biotherapeutics, Inc. | 134.95M | 4.40% | 56,049 | 251.00K |
| 345 | VOR | Vor Biopharma Inc. | 134.71M | 6.50% | 681,063 | - |
| 346 | ANTX | AN2 Therapeutics, Inc. | 131.54M | -2.92% | 633,736 | - |
| 347 | EQ | Equillium, Inc. | 130.25M | 5.64% | 184,391 | 4.39M |
| 348 | BDTX | Black Diamond Therapeutics, Inc. | 125.46M | 2.34% | 395,775 | 70.00M |
| 349 | IKT | Inhibikase Therapeutics, Inc. | 122.54M | 1.87% | 1,129,619 | 1.00 |
| 350 | IPHA | Innate Pharma S.A. | 119.96M | 1.59% | 5,234 | 14.84M |
| 351 | GNLX | Genelux Corporation | 118.74M | 9.50% | 347,945 | 8.00K |
| 352 | SGMO | Sangamo Therapeutics, Inc. | 118.28M | - | 7,554,984 | 32.88M |
| 353 | CRDF | Cardiff Oncology, Inc. | 118.27M | - | 436,351 | 593.00K |
| 354 | ACOG | Alpha Cognition Inc. | 115.67M | -4.83% | 35,008 | 7.43M |
| 355 | ALDX | Aldeyra Therapeutics, Inc. | 111.34M | -1.07% | 4,540,655 | - |
| 356 | RANI | Rani Therapeutics Holdings, Inc. | 111.20M | 7.55% | 897,968 | 1.20M |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 106.40M | -1.91% | 572,964 | 65.34K |
| 358 | QTTB | Q32 Bio Inc. | 106.06M | -0.68% | 244,410 | 53.74M |
| 359 | ONCY | Oncolytics Biotech Inc. | 102.23M | 2.87% | 388,743 | - |
| 360 | HURA | TuHURA Biosciences, Inc. | 102.00M | 1.02% | 360,127 | - |
| 361 | TTRX | Turn Therapeutics Inc. | 100.41M | 2.10% | 4,139 | - |
| 362 | COYA | Coya Therapeutics, Inc. | 98.40M | 1.08% | 185,022 | 7.95M |
| 363 | CGTX | Cognition Therapeutics, Inc. | 97.98M | 0.91% | 1,017,720 | - |
| 364 | SEER | Seer, Inc. | 97.33M | 1.47% | 159,957 | 16.58M |
| 365 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 96.81M | 0.18% | 535,222 | - |
| 366 | SPRB | Spruce Biosciences, Inc. | 96.00M | 8.72% | 99,449 | 697.00K |
| 367 | KPTI | Karyopharm Therapeutics Inc. | 95.57M | -4.23% | 1,655,277 | 146.07M |
| 368 | FBIO | Fortress Biotech, Inc. | 92.80M | 2.40% | 424,276 | 62.30M |
| 369 | ANIX | Anixa Biosciences, Inc. | 90.53M | 4.25% | 131,599 | - |
| 370 | PYXS | Pyxis Oncology, Inc. | 89.85M | 5.15% | 189,539 | 13.86M |
| 371 | GOSS | Gossamer Bio, Inc. | 89.54M | 10.61% | 15,000,633 | 48.47M |
| 372 | MAIA | MAIA Biotechnology, Inc. | 89.19M | 2.08% | 484,436 | - |
| 373 | BMEA | Biomea Fusion, Inc. | 88.21M | 7.96% | 1,935,029 | - |
| 374 | MCRB | Seres Therapeutics, Inc. | 87.62M | 10.39% | 46,116 | 789.00K |
| 375 | NRXS | NeurAxis, Inc. | 84.02M | 6.52% | 181,907 | 3.57M |
| 376 | VANI | Vivani Medical, Inc. | 82.44M | 0.89% | 84,889 | - |
| 377 | PLRX | Pliant Therapeutics, Inc. | 81.11M | 2.34% | 289,837 | - |
| 378 | CSBR | Champions Oncology, Inc. | 80.54M | -0.17% | 7,291 | 57.95M |
| 379 | NRXP | NRx Pharmaceuticals, Inc. | 79.69M | 13.15% | 2,587,098 | 1.23M |
| 380 | KZIA | Kazia Therapeutics Limited | 79.54M | 2.38% | 106,745 | 1.27M |
| 381 | VRCA | Verrica Pharmaceuticals Inc. | 79.37M | 3.12% | 65,314 | 35.58M |
| 382 | GUTS | Fractyl Health, Inc. | 79.32M | 16.17% | 7,510,335 | 3.00K |
| 383 | ATYR | aTyr Pharma, Inc. | 78.37M | 1.23% | 1,475,526 | 190.00K |
| 384 | PYPD | PolyPid Ltd. | 78.10M | 5.15% | 72,011 | - |
| 385 | AARD | Aardvark Therapeutics, Inc. | 77.23M | -6.10% | 249,347 | - |
| 386 | DWTX | Dogwood Therapeutics, Inc. | 77.16M | -10.81% | 98,579 | - |
| 387 | IBIO | iBio, Inc. | 75.30M | 4.81% | 678,119 | 300.00K |
| 388 | PTHS | Pelthos Therapeutics Inc. | 74.12M | 0.41% | 3,846 | 16.80M |
| 389 | CING | Cingulate Inc. | 73.96M | -5.22% | 536,067 | - |
| 390 | PMVP | PMV Pharmaceuticals, Inc. | 73.06M | -1.44% | 407,119 | - |
| 391 | GRCE | Grace Therapeutics, Inc. | 72.57M | 5.63% | 912,262 | - |
| 392 | XBIT | XBiotech Inc. | 71.95M | 0.21% | 25,420 | - |
| 393 | MNOV | MediciNova, Inc. | 71.86M | 0.69% | 45,812 | 409.66K |
| 394 | GANX | Gain Therapeutics, Inc. | 70.75M | 5.38% | 423,756 | - |
| 395 | COEP | Coeptis Therapeutics Holdings, Inc. | 69.64M | 7.60% | 31,058 | 1.36M |
| 396 | BYSI | BeyondSpring Inc. | 69.08M | 3.70% | 12,384 | 1.88M |
| 397 | IFRX | InflaRx N.V. | 67.98M | -7.81% | 386,014 | 34.44K |
| 398 | ACET | Adicet Bio, Inc. | 65.35M | 1.79% | 76,456 | - |
| 399 | ANVS | Annovis Bio, Inc. | 62.95M | -6.33% | 533,721 | - |
| 400 | IBO | Impact BioMedical Inc. | 62.84M | -6.00% | 188,630 | 32.00K |
| 401 | ATHE | Alterity Therapeutics Limited | 61.81M | 2.40% | 3,176 | 4.43M |
| 402 | HYFT | MindWalk Holdings Corp. | 60.59M | 1.67% | 127,190 | 20.70M |
| 403 | EXOZ | eXoZymes, Inc. | 60.39M | -0.69% | 2,268 | -700.00 |
| 404 | IMA | ImageneBio, Inc. | 59.24M | 2.77% | 16,004 | 800.00K |
| 405 | TCRX | TScan Therapeutics, Inc. | 59.18M | 0.97% | 344,654 | 10.33M |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 58.89M | -3.80% | 788,517 | - |
| 407 | TIL | Instil Bio, Inc. | 58.32M | 0.47% | 12,481 | - |
| 408 | ICCC | ImmuCell Corporation | 58.26M | 0.78% | 2,936 | 27.64M |
| 409 | MREO | Mereo BioPharma Group plc | 55.83M | 4.11% | 925,001 | 500.00K |
| 410 | EDSA | Edesa Biotech, Inc. | 54.85M | -6.41% | 525,714 | - |
| 411 | OKUR | OnKure Therapeutics, Inc. | 54.69M | 0.50% | 176,128 | - |
| 412 | LPCN | Lipocine Inc. | 54.24M | 0.95% | 124,582 | 1.98M |
| 413 | ENTX | Entera Bio Ltd. | 54.11M | 14.56% | 285,111 | 124.00K |
| 414 | IMMP | Immutep Limited | 54.02M | 1.94% | 633,059 | 5.28M |
| 415 | ACTU | Actuate Therapeutics, Inc. | 53.92M | 4.98% | 122,216 | - |
| 416 | MGX | Metagenomi Therapeutics, Inc. | 52.29M | 1.46% | 221,583 | 25.21M |
| 417 | RADX | Radiopharm Theranostics Limited | 51.15M | 4.59% | 227,784 | 10.86M |
| 418 | OSTX | OS Therapies Incorporated | 50.71M | 4.35% | 346,319 | - |
| 419 | XLO | Xilio Therapeutics, Inc. | 49.32M | 1.91% | 44,794 | 43.77M |
| 420 | KZR | Kezar Life Sciences, Inc. | 47.45M | 1.09% | 11,132 | - |
| 421 | DCOY | Decoy Therapeutics Inc. | 46.89M | 1.10% | 6,648 | - |
| 422 | ATOS | Atossa Therapeutics, Inc. | 46.67M | -1.63% | 130,343 | - |
| 423 | NTRB | Nutriband Inc. | 45.73M | 1.33% | 11,068 | 2.28M |
| 424 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | 3.91% | 63,690 | - |
| 425 | RLYB | Rallybio Corporation | 45.62M | -0.52% | 57,174 | 858.00K |
| 426 | LSTA | Lisata Therapeutics, Inc. | 45.25M | -0.20% | 17,294 | 170.00K |
| 427 | GOVX | GeoVax Labs, Inc. | 45.09M | -2.60% | 38,581 | 3.35M |
| 428 | LITS | Lite Strategy, Inc. | 43.63M | - | 234,847 | - |
| 429 | ALGS | Aligos Therapeutics, Inc. | 43.07M | 2.50% | 28,398 | 2.19M |
| 430 | INKT | MiNK Therapeutics, Inc. | 42.83M | 6.60% | 36,784 | - |
| 431 | PSTV | Plus Therapeutics, Inc. | 42.18M | 2.50% | 3,363,750 | 5.21M |
| 432 | ATRA | Atara Biotherapeutics, Inc. | 40.56M | -0.60% | 66,119 | 120.77M |
| 433 | RNXT | RenovoRx, Inc. | 40.31M | 1.85% | 403,217 | 928.00K |
| 434 | APLM | Apollomics, Inc. | 38.37M | 1.88% | 2,179 | 6.93M |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 37.87M | 1.32% | 178,964 | 1.14M |
| 436 | NBY | NovaBay Pharmaceuticals, Inc. | 37.81M | -5.33% | 387,297 | 10.30M |
| 437 | CRVO | CervoMed Inc. | 37.41M | 3.06% | 17,000 | 4.01M |
| 438 | SER | Serina Therapeutics, Inc. | 37.31M | 24.69% | 3,271,661 | 116.00K |
| 439 | SNSE | Sensei Biotherapeutics, Inc. | 37.21M | -1.60% | 75,638 | - |
| 440 | ESLA | Estrella Immunopharma, Inc. | 37.02M | 0.54% | 86,764 | - |
| 441 | VERU | Veru Inc. | 36.76M | - | 29,636 | 16.89M |
| 442 | NXTC | NextCure, Inc. | 36.28M | 2.52% | 37,674 | - |
| 443 | PTN | Palatin Technologies, Inc. | 36.24M | 5.79% | 10,257 | 8.96M |
| 444 | LONA | LeonaBio, Inc. | 35.61M | 0.11% | 37,411 | - |
| 445 | CELU | Celularity Inc. | 34.89M | -4.72% | 20,177 | 40.58M |
| 446 | RNTX | Rein Therapeutics Inc. | 34.17M | 6.56% | 57,309 | - |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 33.69M | 0.93% | 40,499 | 90.00K |
| 448 | PLUR | Pluri Inc. | 33.47M | 9.18% | 1,167 | 1.34M |
| 449 | INMB | INmune Bio Inc. | 32.43M | 3.39% | 232,396 | 50.00K |
| 450 | TLSA | Tiziana Life Sciences Ltd | 32.08M | 2.27% | 95,784 | - |
| 451 | DYAI | Dyadic International, Inc. | 31.79M | 3.32% | 101,195 | 3.34M |
| 452 | PDSB | PDS Biotechnology Corporation | 31.09M | 15.38% | 817,121 | - |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 30.86M | -2.08% | 46,426 | - |
| 454 | JSPR | Jasper Therapeutics, Inc. | 30.50M | -5.22% | 315,314 | - |
| 455 | HYPD | Hyperion DeFi, Inc. | 29.96M | 8.50% | 617,974 | 345.32K |
| 456 | CVM | CEL-SCI Corporation | 29.86M | 3.22% | 30,008 | - |
| 457 | XCUR | Exicure, Inc. | 29.38M | 3.13% | 17,278 | 500.00K |
| 458 | BCTX | BriaCell Therapeutics Corp. | 29.31M | -1.22% | 183,533 | - |
| 459 | CRIS | Curis, Inc. | 27.99M | -2.08% | 434,860 | 9.44M |
| 460 | KYNB | Kyntra Bio, Inc. | 27.48M | 0.59% | 13,627 | 6.44M |
| 461 | ABVC | ABVC BioPharma, Inc. | 27.48M | -4.42% | 41,106 | 797.92K |
| 462 | CUE | Cue Biopharma, Inc. | 25.80M | 3.65% | 656,183 | 27.47M |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 25.72M | 5.48% | 144,268 | - |
| 464 | BOLD | Boundless Bio, Inc. | 25.32M | - | 30,005 | - |
| 465 | LTRN | Lantern Pharma Inc. | 24.83M | -0.45% | 28,545 | - |
| 466 | IGC | IGC Pharma, Inc. | 24.33M | 3.56% | 267,843 | 1.11M |
| 467 | VTGN | Vistagen Therapeutics, Inc. | 24.18M | -0.97% | 388,078 | 789.00K |
| 468 | XTLB | XTL Biopharmaceuticals Ltd. | 23.89M | 3.75% | 56,403 | 968.00K |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 23.56M | -3.10% | 10,741 | 14.99M |
| 470 | TPST | Tempest Therapeutics, Inc. | 23.46M | -0.57% | 654,035 | - |
| 471 | SNTI | Senti Biosciences, Inc. | 23.16M | 2.30% | 85,851 | - |
| 472 | PLRZ | Polyrizon Ltd. | 22.89M | 4.79% | 23,310 | - |
| 473 | PASG | Passage Bio, Inc. | 22.76M | 6.05% | 30,362 | - |
| 474 | LGVN | Longeveron Inc. | 22.64M | 8.91% | 567,058 | 1.20M |
| 475 | BRNS | Barinthus Biotherapeutics plc | 22.47M | -1.08% | 7,218 | 14.97M |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.34M | 6.35% | 189,372 | 3.55M |
| 477 | SKYE | Skye Bioscience, Inc. | 20.86M | -0.03% | 153,019 | - |
| 478 | NNVC | NanoViricides, Inc. | 20.45M | -0.33% | 189,846 | - |
| 479 | VYNE | VYNE Therapeutics Inc. | 20.36M | 1.90% | 189,937 | 570.00K |
| 480 | DARE | Daré Bioscience, Inc. | 20.00M | 2.94% | 44,588 | -57.13K |
| 481 | LEXX | Lexaria Bioscience Corp. | 19.28M | -0.92% | 61,755 | 522.00K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 18.04M | 2.02% | 26,615 | - |
| 483 | FBLG | FibroBiologics, Inc. | 17.81M | 2.41% | 1,278,616 | - |
| 484 | ALLR | Allarity Therapeutics, Inc. | 17.71M | - | 62,669 | - |
| 485 | OTLK | Outlook Therapeutics, Inc. | 17.28M | 5.00% | 6,177,893 | 205.70K |
| 486 | LIXT | Lixte Biotechnology Holdings, Inc. | 17.06M | 10.74% | 203,152 | - |
| 487 | QNTM | Quantum BioPharma Ltd. | 16.67M | -8.03% | 1,172,586 | - |
| 488 | INTS | Intensity Therapeutics, Inc. | 16.17M | 7.77% | 29,639 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 16.11M | 1.41% | 426,813 | 3.94M |
| 490 | TRAW | Traws Pharma, Inc. | 15.98M | -6.98% | 71,755 | 2.85M |
| 491 | INAB | IN8bio, Inc. | 15.85M | 3.87% | 190,714 | - |
| 492 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.98M | 15.87% | 4,146,662 | - |
| 493 | COCP | Cocrystal Pharma, Inc. | 14.89M | 1.89% | 32,292 | - |
| 494 | GTBP | GT Biopharma, Inc. | 14.67M | -2.13% | 371,724 | - |
| 495 | PHIO | Phio Pharmaceuticals Corp. | 14.64M | 3.28% | 187,984 | - |
| 496 | GNTA | Genenta Science S.p.A. | 14.37M | 4.21% | 91,048 | - |
| 497 | AEON | AEON Biopharma, Inc. | 14.08M | -3.77% | 180,693 | - |
| 498 | HOTH | Hoth Therapeutics, Inc. | 13.94M | 1.40% | 121,614 | - |
| 499 | IOBT | IO Biotech, Inc. | 13.87M | 0.94% | 668,671 | - |
| 500 | MBRX | Moleculin Biotech, Inc. | 13.29M | 10.67% | 199,772 | - |